CPT® Code 86903

Deleted

1. Indications

The procedure associated with CPT® Code 86903 is indicated for the following:

• Blood Transfusion Preparation Screening of donated blood units to ensure compatibility with the recipient's blood type before a transfusion.
• Antibody Identification Identification of antibodies in the donated blood that may react with the recipient's blood type.
• Emergency Situations Situations where rapid blood typing is necessary, particularly when there is insufficient time for a comprehensive antibody test.

2. Procedure

The procedure for blood typing and antigen screening as described by CPT® Code 86903 involves several key steps:

• Step 1: Collection of Blood Sample A blood sample is collected from the donor, which will be screened for compatibility with potential recipients. This sample is essential for the subsequent testing process.
• Step 2: Preparation of Reagent Serum Reagent serum is prepared, which contains known antibodies that will react with specific antigens present on the surface of red blood cells. This preparation is crucial for accurately identifying any incompatibilities.
• Step 3: Screening Process The blood sample is mixed with the reagent serum. The mixture is then observed for any agglutination, which indicates a reaction between the antibodies in the serum and the antigens on the red blood cells. This step is vital for determining whether the blood unit is compatible with the recipient.
• Step 4: Interpretation of Results The results of the screening are interpreted by qualified personnel. If agglutination occurs, it suggests that the blood unit is not compatible with the recipient's blood type, and alternative units must be considered.

3. Post-Procedure

After the screening procedure is completed, the results are documented and communicated to the healthcare team responsible for the transfusion. If the blood unit is deemed compatible, it can be prepared for transfusion. In cases where incompatibility is identified, further testing may be required to find an appropriate blood unit. It is essential to monitor the recipient for any adverse reactions during and after the transfusion process, ensuring patient safety and effective care.